Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Garware Synthetics Ltd

GARWSYN
BSE
24.00
0.00%
Last Updated:
30 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Garware Synthetics Ltd

GARWSYN
BSE
24.00
0.00%
30 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
14Cr
Close
Close Price
24.00
Industry
Industry
Textiles - Others
PE
Price To Earnings
26.97
PS
Price To Sales
1.31
Revenue
Revenue
11Cr
Rev Gr TTM
Revenue Growth TTM
0.75%
PAT Gr TTM
PAT Growth TTM
235.71%
Peer Comparison
How does GARWSYN stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
GARWSYN
VS

Quarterly Results

Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
332333333332
Growth YoY
Revenue Growth YoY%
-20.1-1.0-17.4-0.7-5.1-7.612.2-6.35.4-2.62.5-2.4
Expenses
ExpensesCr
332333323232
Operating Profit
Operating ProfitCr
000000000000
OPM
OPM%
2.28.33.26.6-5.41.52.52.4-3.69.610.913.7
Other Income
Other IncomeCr
100000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000000000
Tax
TaxCr
000000000000
PAT
PATCr
100000000000
Growth YoY
PAT Growth YoY%
352.00.0200.0-77.8333.3115.0-433.3-92.971.4300.0320.0
NPM
NPM%
22.9-1.0-8.11.15.42.61.1-3.90.44.64.28.8
EPS
EPS
0.70.1-0.30.10.30.10.1-0.20.00.20.30.4

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
8891011981311111111
Growth
Revenue Growth%
9.1-2.58.012.510.8-14.3-9.353.7-10.2-6.20.3-0.5
Expenses
ExpensesCr
888911971211101110
Operating Profit
Operating ProfitCr
000000111001
OPM
OPM%
-1.41.14.95.10.33.212.87.67.53.50.57.5
Other Income
Other IncomeCr
100000000010
Interest Expense
Interest ExpenseCr
000000010000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
0010-10110001
Tax
TaxCr
000000000000
PAT
PATCr
1000-10101000
Growth
PAT Growth%
616.2-72.8181.5-26.5-499.0108.0427.9-60.5151.2-108.3127.33,515.4
NPM
NPM%
7.62.15.53.6-12.91.27.01.85.1-0.50.14.4
EPS
EPS
1.10.30.80.6-2.40.31.10.41.0-0.10.00.9

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
666666666666
Reserves
ReservesCr
-9-8-8-7-9-9-8-8-8-8-8-8
Current Liabilities
Current LiabilitiesCr
5554431616991514
Non Current Liabilities
Non Current LiabilitiesCr
10109111313048822
Total Liabilities
Total LiabilitiesCr
131313141413141715151414
Current Assets
Current AssetsCr
222332333222
Non Current Assets
Non Current AssetsCr
111111111111111413121212
Total Assets
Total AssetsCr
131313141413141715151414

Cash Flow

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
0000-2-101100
Investing Cash Flow
Investing Cash FlowCr
0000000-1000
Financing Cash Flow
Financing Cash FlowCr
000020-1-1000
Net Cash Flow
Net Cash FlowCr
00000000000
Free Cash Flow
Free Cash FlowCr
0000-2-101100
CFO To PAT
CFO To PAT%
-6.985.656.471.5130.4-474.970.2577.998.9-810.7320.0
CFO To EBITDA
CFO To EBITDA%
36.5157.062.950.3-6,107.5-179.638.6137.667.1104.677.9

Ratios

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
22967213851016
Price To Earnings
Price To Earnings
36.754.812.220.10.05.75.336.58.30.01,395.0
Price To Sales
Price To Sales
2.81.20.70.70.20.10.40.70.40.91.5
Price To Book
Price To Book
-8.3-3.6-3.1-4.7-0.8-0.2-1.4-3.3-2.5-4.7-8.2
EV To EBITDA
EV To EBITDA
-231.8151.523.934.3491.045.814.621.012.440.5399.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
39.546.749.145.943.348.554.443.542.547.143.9
OPM
OPM%
-1.41.14.95.10.33.212.87.67.53.50.5
NPM
NPM%
7.62.15.53.6-12.91.27.01.85.1-0.50.1
ROCE
ROCE%
34.718.326.35.4-12.32.610.112.217.16.85.5
ROE
ROE%
-22.7-6.6-25.8-23.448.3-4.0-27.1-9.0-29.42.3-0.7
ROA
ROA%
4.91.33.62.5-10.10.84.31.43.8-0.30.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Garware Synthetics Limited is an established Indian manufacturer specializing in high-quality synthetic materials, primarily serving the industrial brush and medical healthcare sectors. Operating under the recognized brand name **'GARFLON'**, the company has carved a niche in the production of specialized filaments and bristles, positioning itself as a key player in import substitution for critical medical components. --- ### **Core Product Portfolio & Specialized Applications** The company operates a single primary business segment: **Nylon Bristles, Rods & Tubes**. Its manufacturing expertise lies in processing high-performance polymers into specialized forms. * **Synthetic Bristles & Filaments:** Produced from a diverse range of materials including **Nylon 6, 66, 610, PBT (Polybutylene Terephthalate), and Polypropylene**. These are primarily supplied to the **Industrial Brush Industry**. * **Medical Innovation (Nylon Sutures):** A significant strategic pivot for the company is the development of **Nylon Sutures**. Traditionally an imported commodity in India, Garware’s domestic production serves as a critical medical-grade alternative for healthcare providers. * **Industrial Components:** The company also manufactures industrial **Rods & Tubes** for various engineering applications. --- ### **Manufacturing Infrastructure & Operational Capacity** All manufacturing operations are centralized at the company’s facility in Maharashtra. While the company possesses significant installed capacity, current utilization is hampered by external and internal constraints. | Metric | Details | | :--- | :--- | | **Location** | Mira Road (East), Dist. Thane - **401 104** | | **Total Production Capacity** | **570 MT** per year | | **Workforce** | **68 employees** (as of March 31, 2024) | | **Brand Identity** | **'GARFLON'** | **Energy Consumption Trends** Energy is a primary cost driver for the company. Recent data indicates a rising cost per unit, impacting overall production overheads. | Particulars | F.Y. 2024-2025 | F.Y. 2023-2024 | F.Y. 2022-2023 | | :--- | :---: | :---: | :---: | | **Electricity Consumption (Lakh KWH)** | **8.13** | **7.30** | **7.64** | | **Total Energy Value (Rs. Lakhs)** | **89.81** | **70.80** | **65.62** | | **Cost per Unit (Rs.)** | **27.46** | **21.95** | **19.86** | | **Consumption per Ton of Production** | **27,461** | **21,948** | **19,858** | --- ### **Financial Performance & Capital Structure** The company’s recent financial trajectory shows a strategic shift toward profitability over aggressive revenue growth. In **FY 2022-23**, the company achieved a significant **151% increase in Net Profit** despite a contraction in top-line revenue. **Key Financial Metrics** | Metric | FY 2022-23 (INR) | FY 2021-22 (INR) | Growth/Change | | :--- | :--- | :--- | :--- | | **Revenue from Operations** | **11,40,05,668** | **12,70,12,821** | **-10.24%** | | **Net Profit** | **57,82,273** | **23,02,463** | **+151.13%** | | **Basic/Diluted EPS** | **1.00** | **0.40** | **+150.00%** | | **Paid-up Capital** | **5,80,89,000** | **5,80,89,000** | **0%** | **Capital Details:** * **Authorized Share Capital:** **Rs. 10,00,00,000** (99.5 Lakh Equity Shares and 5,000 Preference Shares). * **Paid-up Equity Capital:** **Rs. 5,80,89,000** (58,08,900 Equity Shares at **Rs. 10** each). * **Dividend Policy:** The Board did **not recommend a dividend** for the recent fiscal years, opting to retain earnings to bolster financial stability and fund future expansion. --- ### **Strategic Leadership & Governance** The company has recently stabilized its leadership team with long-term appointments to oversee its next phase of growth. * **Executive Leadership:** * **Ms. Ujwala Somnath Tate (CEO):** Appointed for a **5-year term** ending **December 2029**. * **Mr. Sunder Moolya (Whole-time Director):** Re-appointed for a **5-year term** ending **May 2029**. * **Mrs. Shilpa Parab (Independent Director):** Re-appointed for a second **5-year term** ending **September 2029**. * **Operational Support:** Following an NCLT-approved merger, the company transitioned its Registrar and Share Transfer Agent (RTA) to **Link Intime India Private Limited** in **April 2024**. * **Compliance Framework:** The company adheres to **Ind AS** and maintains an **Audit Committee** to oversee internal controls, though it currently lacks a formal **Internal Auditor** as per **Section 138 of the Companies Act**. --- ### **Growth Strategy & Market Outlook** Management is positioning the company to capitalize on the projected **7.5% growth** in the Indian industrial and services sectors. * **Import Substitution:** By focusing on high-quality standards, the company aims to replace expensive imported synthetic materials, particularly in the medical sector. * **Technology Adaptation:** While there are no active formal R&D projects, the company focuses on **Technology Adaptation and Innovation** to refine the **Garflon** product line. * **Market Expansion:** The Board is actively exploring new business avenues within the **Garflon** field to diversify revenue streams. --- ### **Risk Factors & Operational Constraints** Investors should note several headwinds that impact the company’s ability to scale: * **Financial Constraints:** A persistent **scarcity of Working Capital** is the primary factor preventing the company from reaching its full **570 MT** production capacity. * **Input Cost Volatility:** As a manufacturer of petro-based products, the company is highly sensitive to **oil price fluctuations**. High raw material costs have historically pressured profit margins. * **Infrastructure Issues:** The Thane facility faces significant **power shortages** and frequent power-cutting, leading to production losses. * **Regulatory & Listing Risks:** * The **Calcutta Stock Exchange** has previously flagged non-compliance with **Minimum Public Shareholding** requirements, leading to the freezing of certain promoter demat accounts. * **Contingent Liabilities:** The company faces **Rs. 110.11 Lakhs** in Provident Fund-related claims and **Rs. 0.15 Lakhs** in Income Tax disputes as of **FY 2024-25**. * **Property Disputes:** Title deeds for certain immovable properties are not currently held in the company’s name and are subject to legal dispute. * **Competitive Landscape:** The company faces intense pressure from the **unorganized sector**, which often competes on price rather than the high-quality standards maintained by Garware.